Atorvastatin before flow diverter for brain aneurysms
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether taking atorvastatin before a flow diverter procedure can prevent strokes or other brain events in people with unruptured brain aneurysms. It may help reduce complications from the treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have an unruptured brain aneurysm (not previously treated) that is 3 to 25 mm in size.
- Your doctor plans to treat it with a flow diverter (a small mesh tube placed in the artery), with or without coils.
- You are not pregnant or breastfeeding and can take atorvastatin safely (no allergies or conflicts with other medicines).
- You have not been on statins for 30 days or more, and you do not have other serious vascular problems like heart disease or stroke history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This study uses detailed 3D X-rays and ultrasound to understand how blood flows through a mesh tube (flow diverter) placed in a brain aneurysm. It may help doctors predict and prevent narrowing inside the tube.
This trial tests a flow-diverter stent (a small mesh tube) to treat brain aneurysms that are hard to close with standard methods. It may help if you have a wide-neck or other complex aneurysm that hasn't burst.
This trial tests a flow-diverting stent for treating certain brain aneurysms located in distal parts of the brain's arteries. It’s for people who have already received this stent and are between 18 and 80 years old.
This study tests a new stent, a small mesh tube placed inside the artery to block blood flow to a wide-neck brain aneurysm, reducing its rupture risk. It aims to see how safe and effective this stent is for people aged 22–80.
This trial tests a special stent (DERIVO) for brain aneurysms that have come back after earlier treatment. It's for people who cannot have other treatments like coiling or surgery.
Hear when a new Cerebrovascular Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.